跳至主要内容
临床试验/NL-OMON22232
NL-OMON22232尚未招募不适用

Safety and immunogenicity of seasonal and pandemic inactivated whole virion influenza vaccine in healthy adults.

RIVM, Bilthoven0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
150

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age 18 to 49 years;
  • 2. If female: Willing to use contraceptive measures during the study;

排除标准

  • 1. Having had an infectious disease with fever (including influenza) within the last 14 days;
  • 2. Present evidence of serious disease(s) demanding medical treatment that might interfere with the results of the study such as diseases which interfere with the immune system;

研究者

发起方
RIVM, Bilthoven

相似试验